
Mydacla Tablet - Daclatasvir Dihydrocloride 60mg, Effective Direct-acting Antiviral For Chronic Hcv Genotype 3 Treatment, Low Side Effects & Long Shelf Life
Price:
Get Latest Price
In Stock
Product Specifications
| Product Type | Tablet |
| Ingredients | Daclatasvir |
| Physical Form | Solid (Tablet) |
| Treatments & Functions | Used in the treatment of Hepatitis C infection |
| Age Group | Adults |
| Dosage Guidelines | As prescribed by a healthcare professional; typically one tablet per day |
| Quantity | 28 tablets per pack |
| Packaging | Aluminium foil blister packing |
| Storage Instructions | Store below 30A C protect from light and moisture |
| Lead Time | 2-3 weeks after order confirmation |
| Feature | High efficacy in patients with Hepatitis C convenient oral dosage form |
| Precautions | Use under medical supervision not recommended for pregnant or breastfeeding women |
| Appearance | Round biconvex film-coated tablet |
| Composition | Each tablet contains 60 mg of Daclatasvir |
| Color | Light yellow |
| Weight | 500 mg per tablet |
| Main Export Market(s) | Africa |
| GSTIN | 0% |
Company Details
Focusing on a customer-centric approach, PRISSM PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pain Relief Drugs & Medicines in bulk from PRISSM PHARMA at Trade India quality-assured products.
Business Type
Exporter, Distributor, Trading Company
Employee Count
10
Establishment
1991
Working Days
To
GST NO
27AARFP5752B1Z1
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AARFP5752B1Z1
Mumbai, Maharashtra
Proprietor
Mr Amith Dhiraj Galaa
Address
12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E), Mumbai, Maharashtra, 400011, India
Report incorrect details









































